HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 466961Erstellt: 26. Oktober 2026
Citric Acid → 4-(5-Bromopentyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one
https://huagongshe.com/reaction/466961
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Citric Acid | HCID 311 | — |
| Edukt | 1,5-Dibromopentane | HCID 8100 | — |
| Edukt | Sodium hydride | HCID 24758 | — |
| Edukt | 2,3,4,5-Tetrahydro-1,4-benzoxazepin-5-one | HCID 340629 | — |
| Lösungsmittel | Dimethylformamide | HCID 6228 | — |
| Produkt | 4-(5-Bromopentyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one | HCID 19813056 | 65% |
Reaktionsschritte
In 20 ml of dimethylformamide (DMF) was dissolved 100 mg of 2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one, and the solution then ice-cooled. Then, to the resulting solution were added 0.251 ml (3 equivalents) of 1,5-dibromopentane and 29.4 mg (1.2 equivalent) of a 60% sodium hydride oil dispersion, and the mixture was stirred for one hour with ice-cooling. The reaction solution was poured into a citric acid aqueous solution and extracted with ethyl acetate, and the ethyl acetate phase was washed with an aqueous saturated sodium chloride solution, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was then concentrated and the resulting residue was purified by silica gel column chromatography (eluent: hexane/ethyl acetate (8:2)) to give 124 mg (yield: 65.0%) of the title compound.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US05158947 |
|---|
| Quelldatensatz | uspto-grants-1992_10 |
|---|
| ORD ID | ord-5a307d9441d2491899e5958bbc821fa0 |
|---|
| Quellennotiz | uspto-grants-1992_10 |
|---|